Immune Design Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Corporate Update
pharmaceutical investing Immune Design Receives Orphan Drug Designation for G100 Intratumoral Product Candidate
West High Yield Resources Ltd. Announces Court Dismisses Judicial Review Challenging Record Ridge Project
